Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - UDG Healthcare plc

1st Jun 2021 07:00

RNS Number : 2839A
Societe Generale SA
01 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Société Générale S.A.

Company dealt in

UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

€0.05 ordinary shares

Date of dealing

28/05/2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

3,593,635

1.43

205,320

0.08

(2) Derivatives (other than options)

200,467

0.08

0

0.00

(3) Options and agreements to purchase/sell

0

0.00

0

0.00

Total

*3,854,102

*1.53

205,320

0.08

* Include the holding of 60,000 shares on borrow products

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit GBP (Note 5)

Purchase

666

10.58

Purchase

2,177

10.58

Purchase

1,276

10.58

Purchase

696

10.58

Purchase

285

10.56

Purchase

221

10.56

Purchase

200

10.56

Purchase

155

10.56

Purchase

565

10.56

Purchase

429

10.58

Purchase

57

10.57

Purchase

200

10.57

Purchase

56

10.57

Purchase

1,142

10.56

Purchase

1,213

10.57

Purchase

428

10.56

Purchase

24

10.57

Purchase

194

10.57

Purchase

407

10.58

Purchase

429

10.57

Purchase

454

10.58

Purchase

703

10.59

Purchase

283

10.59

Purchase

827

10.58

Purchase

1,879

10.58

Purchase

1,179

10.58

Purchase

200

10.58

Purchase

182

10.58

Purchase

56

10.58

Purchase

1,286

10.58

Purchase

1,140

10.58

Purchase

314

10.57

Purchase

227

10.56

Purchase

720

10.56

Purchase

645

10.56

Sale

97,634

10.58

Sale

102,833

10.58

Total Purchases

20,915

 

Total Sales

200,467

 

 

Derivatives transactions (other than options transactions)

 

Product name,e.g. CFD

Nature of transaction(Note 6)

Number of relevant securities(Note 7)

Price per unit GBP(Note 5)

CFD

Opening long

97,634

10.58

CFD

Opening long

102,833

10.58

 

(b) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

(c) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

 

Agreements, arrangements, or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of anyrelevant securities to which any derivative referred to on this form is referenced. If none, thisshould be stated.

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  No

 

Date of disclosure

31/05/2021

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEWPUQPAUPGUCG

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00